95267 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings linked by a carbon chain containing aromatic rings
NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS
#2COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#3COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#4COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#5MATERIAL FOR PHOTOELECTRIC CONVERSION ELEMENT FOR IMAGING, AND PHOTOELECTRIC CONVERSION ELEMENT
#6COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#7ANTHRACENE DERIVATIVE COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#8Luminescent probe and its preparation method and application
#9Novel Compound and Organic Light Emitting Device Comprising the Same
#10NOVEL ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
#11AMYLOID TARGETING AGENTS AND METHODS OF USING THE SAME
#12ORGANIC COMPOUNDS AND USES THEREOF
#13Composition for organic optoelectronic device, organic optoelectronic device, and display device
#14Composition for organic optoelectronic device, organic optoelectronic device, and display device
#15ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#16COMPOUNDS AND APPLICATIONS THEREOF IN FIELD OF OPTOELECTRONICS
#17Composition for organic optoelectronic device, organic optoelectronic device, and display device
#18PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#19NOVEL TRICYCLIC AROMATIC HETEROCYCLIC COMPOUND AND PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND USE THEREOF
#20Near and shortwave infrared polymethine dyes
#21ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#22POLYCYCLIC COMPOUND AND AN ORGANIC ELECTROLUMINESCENCE DEVICE COMPRISING THE POLYCYCLIC COMPOUND OR THE COMPOSITION
#23Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease
#24COMPOUNDS FOR ELECTRONIC DEVICES
#25ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#26ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#27ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#28ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
#29AROMATIC VINYL OR AROMATIC ETHYL DERIVATIVE, PREPARATION METHOD THEREFOR, INTERMEDIATE, PHARMACEUTICAL COMPOSITION, AND APPLICATION
#30NOVEL COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME, AND ELECTRONIC APPARATUS
#31ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE USING SAME
#32COMPOUNDS FOR INHIBITION OF ALPHA 4 BETA 7 INTEGRIN
#33Pyridazinone compounds and their use as DAAO inhibitors
#34ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME
#35Amyloid targeting agents and methods of using the same
#36ß- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ ß -CATENIN SIGNALING PATHWAY ACTIVATORS
#375,5-Difluoro- and 5-Fluoro-5-Methyl-C-Glycoside Derivatives Useful As Dual SGLT1 / SGLT2 Modulators
#38Method for producing an aromatic dianhydride
#39Condensed cyclic compound and organic light-emitting device including the same
#40Organic compound, and organic light emitting diode and organic light emitting display device including the same
#41Organic compound, organic light emitting diode and organic light emitting device including the organic compound
#42Aromatic vinyl or aromatic ethyl derivative, preparation method therefor, intermediate, pharmaceutical composition, and application
#43Compound and organic electro-optical device containing the same
#44Anticancer 1,3-dioxane-4,6-dione derivatives and method of combinatorial synthesis thereof
#45Glucose-6-Phosphate Dehydrogenase (G6PD)-Modulating Agents And Methods Of Treating G6PD Deficiency
#46Production of tri-methyl benzene derivatives
#47Compounds for inhibition of alpha 4 beta 7 integrin
#48ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
#49Amyloid targeting agents and methods of using the same
#50Pyridazinone compounds and their use as DAAO inhibitors
#51B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS
#52Near-infrared chemiluminescent probes for in-vivo imaging
#53Polycyclic compound and organic light emitting element comprising same
#54Condensed cyclic compound, composition including the condensed cyclic compound, and organic light-emitting device including the condensed cyclic compound
#55Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
#56Substituted oxepines
#57Process for the preparation of D-glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl] oxy]phenyl] methyl] phenyl]-, (1S) and its crystalline forms thereof
#58Compound for photoactive organic electronic components and photoactive organic electronic component containing the compound
#59SPIROCYCLIC DERIVATIVE, AND POLYMER, MIXTURE, FORMULATION AND ORGANIC ELECTRONIC DEVICE COMPRISING THE SAME
#60Organic compound and organic electroluminescent device comprising same
#61β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators
#62Amyloid targeting agents and methods of using the same
#63Organic electroluminescent materials and devices
#64Nitrogen-containing aromatic heterocyclic compound
#65Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device
#66Cathepsin K inhibitors and application thereof
#67Pyridazinone compounds and their use as DAAO inhibitors
#684H-pyran compounds as insulin-regulated aminopeptidase (IRAP) inhibitors
#69Functionalised benzopyran compounds and use thereof
#70Organic electroluminescent materials and devices
#71Liquid crystal compound having benzopyran skeleton, liquid crystal composition, and liquid crystal display device
#72Condensed cyclic compound and organic light-emitting device including the same
#73COMPOSITIONS AND METHODS FOR IMPROVING AGRONOMIC CHARACTERISTICS OF PLANTS
#74Hydrogel Particles, Compositions, and Methods
#75Heterocyclic compounds with benzo(c)coumarin-structures
#76COMPOUND HAVING A DIFLUOROCYCLOHEXANE RING, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE
#77PDE10 inhibitors and related compositions and methods
#78Tetrazole-substituted arylamides as PXand PXantagonists
#79Bicyclic derivatives and pharmaceutical composition including the same
#80Glycoside derivatives and uses thereof
#81Compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient
#82Functionalised benzopyran compounds and use thereof
#83Fullerene derivative, organic solar cell using same, and preparation method therefor
#84Amyloid targeting agents and methods of using the same
#85Substituted oxepines
#86Liquid crystal compound having a 3,6-dihydro-2H-pyran ring, negative dielectric anisotropy, liquid crystal composition and liquid crystal display device
#87Aromatic amine compound, organic electroluminescent element and electronic device
#881,3-dioxane compound having fluorine atom in axial position, liquid crystal composition and liquid crystal display device
#89Materials for organic electroluminescent devices
#90β- and γ-diketones and γ-hydroxyketones as Wnt/β-catenin signaling pathway activators
#91β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators
#92Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#93Diphenylmethane derivatives as SGLT2 inhibitors
#94Dihydrofuran azetidine derivatives as antiparasitic agents
#95Pyridazinone compounds and their use as DAAO inhibitors
#96Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#97Inhibitors of the renal outer medullary potassium channel
#98Dual SGLT1/SGLT2 inhibitors
#99Compound, material for organic electroluminescence device, and organic electroluminescence device
#100METHODS FOR INHIBITION OF SHC-1/P66 TO COMBAT AGING-RELATED DISEASES
#101RESORCYLIC ACID LACTONE COMPOUNDS
#102Cysteinyl leukotriene antagonists
#103Diphenylmethane derivatives as SGLT2 inhibitors
#104β- and γ-diketones and γ-hydroxyketones as / β-catenin signaling pathway activators
#105Iminipyridine derivatives and their uses as microbiocides
#106Cortistatin A analog and use thereof
#107Aromatic amine derivative and organic electroluminescence device using the same
#108Process for preparing divinylarene dioxides
#109Organic electroluminescent element, material for organic electroluminescent element, and light emitting device, display device and illumination device each using the element
#110Antimicrobial agents
#111TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY
#112Organic compounds for electroluminescent devices
#113NOVEL COMPOUNDS
#114Heterocyclic compound and organic light-emitting device containing the same
#115Glycoside derivatives and uses thereof
#116ORGANIC PHOTOELECTRIC CONVERSION MATERIAL AND ORGANIC THIN-FILM PHOTOELECTRIC CONVERSION DEVICE
#117Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#118Triazole compounds that modulate HSP90 activity
#119Glycoside derivative and uses thereof
#120Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#121Glycoside derivatives and uses thereof
#122N-TYPE ORGANIC SEMICONDUCTORS INCLUDING AT LEAST TWO 2-DICYANOMETHYLENE-3-CYANO-2,5-DIHYDROFURAN GROUPS
#123Materials for organic electroluminescent devices
#124β- and γ-diketones and γ-hydroxyketones as /β-catenin signaling pathway activators
#125Organic electroluminescent element material and organic electroluminescent element comprising same
#126Acetanilide sphingosine-1-phosphate receptor antagonists
#127Heteroaryl diamide compounds useful as MMP-13 inhibitors
#128LIGHT-EMITTING ELEMENT MATERIAL AND LIGHT-EMITTING ELEMENT
#129Compounds having CRTH2 antagonist activity
#130PDE10 inhibitors and related compositions and methods
#131Compound having hydrocoumarin skeleton, liquid crystal compostition, and liquid crystal display device
#132NOVEL HERBICIDES
#133Glycoside derivatives and uses thereof
#134Herbicides
#135Oxindolyl inhibitor compounds
#136Iminipyridine derivatives and their uses as microbiocides
#137ASPALATHIN-LIKE DIHYDROCHALCONE, EXTRACTS FROM UNFERMENTED ROOIBOS AND PROCESS FOR PREPARATION
#138Piperazine Compounds Whith a Herbicidal Action
#1394-phenylimidazole-2-thione tyrosinase inhibitors and pharmaceutical/cosmetic applications thereof
#140Compounds having CRTH2 antagonist activity
#141BIPHENYL SUBSTITUTED SPIROTETRONIC ACIDS AND THEIR USE FOR THE TREATMENT OF RETROVIRAL DISEASES
#142Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#143Organic photoelectric conversion material and organic thin-film photoelectric conversion device
#144Benzophenone derivatives useful for inhibiting formation of microtubule
#145Non-steroidal progesterone receptor modulators
#146Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device
#1474-PHENYL-3-(2-PROPYLSULFONYLAMINO) TETRAHYDROFURAN DERIVATIVES WHICH POTENTIATE GLUTAMATE RECEPTORS AND ARE USEFUL IN THE TREATMENT OF SCHIZOPHRENIA
#148AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME
#149C-glycoside derivatives and salts thereof
#150Aromatic amine derivative and organic electroluminescence device employing the same
#151Extraction of theaflavins
#152Process To Obtain Dibenzylbutyrolactonic, Tetrahydrofuranic Lignans And Their Synthetic And Semi-Synthetic Derivatives, Their Analgesic And Anti-Inflammatory Activities, Topical And/Or Systemic Formulations Containing Said Lignans And Their Respective Therapeutic Method
#153Substituted cyclic urea derivatives
#154Aromatic amine derivative and organic electroluminescence device using the same
#155Method of purifying theavlavins
#156Tetrazole-substituted arylamides as P2Xand P2Xantagonists
#157Triazole compounds that modulate HSP90 activity
#158Substituted phenyl methanone derivatives
#159Imino ether derivative compounds and drugs containing the compounds as the active ingredient
#160C-glycoside derivatives and salts thereof
#161Organic electroluminescent device
#162Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#163Aromatic amine derivative and organic electroluminescence device employing the same
#164C-glycoside derivatives and salts thereof
#165D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture
#166D-xylopyranosyl-phenyl-substituted cycles, medicaments containing such compounds, their use and process for their manufacture
#167Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
#1688-(biaryl)quinoline PDE4 inhibitors
#169Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
#170Androgen effectors